Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
By
Chris Graham
Solid neighbourhood-bakery energy. Trustworthy and warm.
Summary
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation. The drug is being hailed as a breakthrough for pancreatic cancer, which is often diagnosed late and is notoriously difficult to treat. More than half of patients die within three months of diagnosis. The study's lead, Dr. Rachna Shroff, describes the results as "landscape-changing" for this patient population.
Key quotes
· 3 pulledThese results are landscape-changing for metastatic pancreatic cancer patients with a KRAS mutation.
Pancreatic cancer is often spotted late and is notoriously difficult to treat.
More than half of people with pancreatic cancer die within three months of diagnosis.
You might also wanna read
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·7h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·7h agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·7h ago
Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds
An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug blocks
bit.ly·10h ago
Woman develops whiplike rash on back after eating shiitake mushrooms
A woman developed bright-red, whiplike rashes on her back after eating shiitake mushrooms, a condition known as shiitake dermatitis. The cas
livescience.com·11h ago
Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
pasadenastarnews.com·13h ago